Haiqing Luo

1.2k total citations · 1 hit paper
36 papers, 823 citations indexed

About

Haiqing Luo is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Haiqing Luo has authored 36 papers receiving a total of 823 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 13 papers in Oncology and 8 papers in Cancer Research. Recurrent topics in Haiqing Luo's work include Cancer-related gene regulation (5 papers), RNA modifications and cancer (5 papers) and Head and Neck Cancer Studies (5 papers). Haiqing Luo is often cited by papers focused on Cancer-related gene regulation (5 papers), RNA modifications and cancer (5 papers) and Head and Neck Cancer Studies (5 papers). Haiqing Luo collaborates with scholars based in China, United States and Hong Kong. Haiqing Luo's co-authors include Xiao Zhu, Lianfang Huang, Hui Luo, Kai Li, Xiangyong Li, Keyuan Zhou, Kai Li, Xin Zhang, Liren Hu and Taiping He and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Scientific Reports.

In The Last Decade

Haiqing Luo

32 papers receiving 819 citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Microsatellite instability: a review of what the oncologist should know

2020 337 citations Kai Li, Haiqing Luo et al. Cancer Cell International profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Haiqing Luo China	13	389	319	287	181	144	36	823
Eva Hernández‐Illán Spain	9	469 1.2×	289 0.9×	325 1.1×	191 1.1×	128 0.9×	16	785
Bao Song China	17	440 1.1×	258 0.8×	351 1.2×	84 0.5×	93 0.6×	33	822
Jonas J. Staudacher United States	11	359 0.9×	321 1.0×	153 0.5×	147 0.8×	94 0.7×	25	693
Haohai Zhang China	17	372 1.0×	201 0.6×	291 1.0×	67 0.4×	130 0.9×	27	784
Chiara Maura Ciniselli Italy	18	407 1.0×	235 0.7×	365 1.3×	124 0.7×	131 0.9×	68	803
Iosune Baraibar Spain	17	319 0.8×	572 1.8×	214 0.7×	208 1.1×	288 2.0×	44	904
Kunitoshi Shigeyasu Japan	16	649 1.7×	202 0.6×	308 1.1×	74 0.4×	119 0.8×	67	951
Shengling Fu China	14	272 0.7×	403 1.3×	158 0.6×	69 0.4×	195 1.4×	37	746
Edlyn Soeth Germany	11	244 0.6×	454 1.4×	212 0.7×	107 0.6×	131 0.9×	17	825
Si-Qi Qiu China	14	303 0.8×	420 1.3×	313 1.1×	112 0.6×	161 1.1×	35	966

Countries citing papers authored by Haiqing Luo

Since Specialization

Citations

This map shows the geographic impact of Haiqing Luo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Haiqing Luo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Haiqing Luo more than expected).

Fields of papers citing papers by Haiqing Luo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Haiqing Luo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Haiqing Luo. The network helps show where Haiqing Luo may publish in the future.

Co-authorship network of co-authors of Haiqing Luo

This figure shows the co-authorship network connecting the top 25 collaborators of Haiqing Luo. A scholar is included among the top collaborators of Haiqing Luo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Haiqing Luo. Haiqing Luo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wu, Qibiao, et al.. (2025). Comparison of TPF and PF induction chemotherapy combined with cisplatin concurrent chemoradiotherapy for locoregionally advanced nasopharyngeal carcinoma: A systematic review and meta-analysis. Medicine. 104(3). e41278–e41278.

Lin, Zhi, Haiqing Luo, Shuang Pan, et al.. (2025). Effects of Paeoniae Radix Rubra on lowering lipid via bioinformatics and gut microbiome. Scientific Reports. 15(1). 21117–21117.

Chen, Lingli, Bing Zhang, Wenyi Qin, et al.. (2024). Tislelizumab plus neoadjuvant chemotherapy and concurrent chemoradiotherapy versus neoadjuvant chemotherapy and concurrent chemoradiotherapy for locally advanced nasopharyngeal carcinoma: A retrospective study. Translational Oncology. 48. 102058–102058. 3 indexed citations

Luo, Haiqing, Bo Yang, Li Li, et al.. (2024). Zebrafish as a promising model for investigating biological activities of ginseng species—a review. Quality Assurance and Safety of Crops & Foods. 16(1). 38–59. 5 indexed citations

Luo, Haiqing, et al.. (2024). MiRNA-296-5p promotes the sensitivity of nasopharyngeal carcinoma cells to cisplatin via targeted inhibition of STAT3/KLF4 signaling axis. Scientific Reports. 14(1). 6681–6681. 4 indexed citations

Hu, Wenjia, Yan Wang, Ran Chen, et al.. (2023). MicroRNA-199a-3p suppresses the invasion and metastasis of nasopharyngeal carcinoma through SCD1/PTEN/AKT signaling pathway. Cellular Signalling. 110. 110833–110833. 4 indexed citations

Luo, Haiqing, Yumeng Huang, Jing Li, et al.. (2022). DHA inhibits invasion and metastasis in NSCLC cells by interfering with CCL18/STAT3 signaling pathway. Clinical and Experimental Medicine. 23(6). 2311–2320. 6 indexed citations

Luo, Haiqing, Chih‐Yu Chen, Xiangyong Li, et al.. (2021). Increased Lipogenesis is Critical for Self-Renewal and Growth of Breast Cancer Stem Cells: Impact of Omega-3 Fatty Acids. Stem Cells. 39(12). 1660–1670. 30 indexed citations

Chen, Chen, Haiqing Luo, Jing Ren, et al.. (2020). MicroRNA-296-5p inhibits cell metastasis and invasion in nasopharyngeal carcinoma by reversing transforming growth factor-β-induced epithelial–mesenchymal transition. Cellular & Molecular Biology Letters. 25(1). 49–49. 11 indexed citations

10.

Luo, Haiqing, et al.. (2020). Cancer neoantigen: Boosting immunotherapy. Biomedicine & Pharmacotherapy. 131. 110640–110640. 49 indexed citations

11.

Huang, Lianfang, et al.. (2020). GWAS in cancer: progress and challenges. Molecular Genetics and Genomics. 295(3). 537–561. 55 indexed citations

12.

Li, Kai, Haiqing Luo, Lianfang Huang, Hui Luo, & Xiao Zhu. (2020). Microsatellite instability: a review of what the oncologist should know. Cancer Cell International. 20(1). 16–16. 337 indexed citations breakdown →

13.

Yu, Haibing, et al.. (2020). A prognostic model guides surgical resection in cervical squamous cell carcinoma. Translational Cancer Research. 9(3). 1711–1731. 17 indexed citations

14.

Li, Xiangyong, Fumei Liu, Bihua Lin, et al.. (2017). miR-150 inhibits proliferation and tumorigenicity via retarding G1/S phase transition in nasopharyngeal carcinoma. International Journal of Oncology. 50(4). 1097–1108. 64 indexed citations

15.

Luo, Haiqing, Meng Xu, Xinhai Zhu, et al.. (2015). Lung cancer cellular apoptosis induced by recombinant human endostatin gold nanoshell-mediated near-infrared thermal therapy.. PubMed. 8(6). 8758–66. 10 indexed citations

16.

Luo, Haiqing, et al.. (2014). Association between 3801T>C Polymorphism of CYP1A1 and Idiopathic Male Infertility Risk: A Systematic Review and Meta-Analysis. PLoS ONE. 9(1). e86649–e86649. 14 indexed citations

17.

Luo, Haiqing, et al.. (2014). Metastasis-associated protein 1 as a new prognostic marker for solid tumors: a meta-analysis of cohort studies. Tumor Biology. 35(6). 5823–5832. 15 indexed citations

18.

Luo, Haiqing, et al.. (2013). Efficacy and tolerability of docetaxel and cisplatin plus S-1 for advanced gastric cancer.. PubMed. 18(1). 154–61. 2 indexed citations

19.

Hu, Liren, et al.. (2013). Poor Prognosis of Phosphatase of Regenerating Liver 3 Expression in Gastric Cancer: A Meta-Analysis. PLoS ONE. 8(10). e76927–e76927. 9 indexed citations

20.

Li, Xiangyong, Yiu‐Kay Lai, Jinfang Zhang, et al.. (2011). Lentivirus-Mediated RNA Interference Targeting Bax Inhibitor-1 Suppresses Ex Vivo Cell Proliferation and In Vivo Tumor Growth of Nasopharyngeal Carcinoma. Human Gene Therapy. 22(10). 1201–1208. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact